 |
|
|
 |
|
|
|
|
 |
|
|
 |
 |
|
|
 |
|
Theresa A.
Shapiro, MD, PhD
Division
Director
Wellcome Professor, Medicine, and Pharmacology
and Molecular Sciences |
|
Research
Interests:
Molecular and clinical pharmacology
of antiparasitic drugs; DNA topoisomerases
as antiparasitic drug targets; structure-activity
of synthetic antimalarial trioxanes
|
|
|
 |
 |
|
Albena Dinkova-Kostova, PhD
Assistant Professor, Medicine, and Pharmacology and Molecular Sciences |
|
Research
Interests:
Protection against cancer – mechanisms and strategies; structure-activity relation of protective agents; inflammation and cancer; skin cancer prevention
|
|
|
|
 |
|
Charles
Flexner, MD
Professor, Medicine, and Pharmacology and
Molecular Sciences, and International Health
(Bloomberg School of Public Health) |
|
Research
Interests:
HIV biology and antiretroviral therapy; basic and clinical pharmacology of antiretroviral drugs.
|
|
|
|
 |
|
Craig
Hendrix, MD
Director,
Drug Development Unit
Professor, Medicine (Clinical Pharmacology, Infectious Diseases) and Pharmacology and Molecular Sciences, and Epidemiology (Bloomberg School of Public Health) |
|
Research
Interests:
Chemoprevention of HIV infection;
topical HIV microbicides; clinical pharmacology
of antiviral drugs; drug interactions
|
|
|
|
 |
|
Walter C. Hubbard, Ph. D.
Director, Mass Spectrometry Laboratory
Associate Professor, Medicine (Clinical Pharmacology and Allergy and Clinical Immunology-secondary) |
|
Research
Interests:
Quantitative LC-MS/MS analysis employing MRM for measurement of concentrations of small molecules in body fluids and cell compartments. Clinical and laboratory research such as: (1) pharmacokinetics and metabolism of agents employed for prevention and treatment of HIV/AIDS and other viral diseases; (2) pharmacokinetics and metabolism of therapeutic agents employed for treatment and management of infectious diseases (tuberculosis and parasitic diseases); (3) lipid molecular species and their potential as diagnostic markers for use in newborn screening for leukodystrophies, other peroxisomal disorders and abnormalities in lipid metabolism in genetically inherited diseases; (4) role (s) of lipids as mediators of signal transduction in cells and; (5) role (s) of lipids in pulmonary obstructive and inflammatory diseases
|
|
|
|
 |
|
Paul
Lietman, MD, PhD
Professor,
Medicine, and Pediatrics, and Pharmacology
and Molecular Sciences |
|
Research
Interests:
Clinical pharmacology of antibacterial and antiviral drugs, development of complementary and alternative medicines, and ethics of human experimentation
|
|
|
|
|
 |
|
Brent
Petty, MD
Hospital
Pharmacologist
Associate
Professor, Medicine, and Pharmacology and
Molecular Sciences |
|
Research
Interests:
Phase I clinical trials;
comparative clinical trials of antimicrobials;
new treatments for peripheral neuropathy;
treatments for macular degeneration; medical
consultation and preoperative testing
|
|
|
|
 |
|
Rahul P. Bakshi, PhD
Research Associate, Medicine |
|
Interests:
Biology of protozoan parasites, pharmacokinetic-pharmacodynamic relationships of drugs, development of anti-infective agents.
|
|
|
|
 |
|
Edward J. Fuchs, PA-C, MBA
Associate Director, Drug Development Unit
Research Associate, Medicine and Epidemiology |
|
Interests:
Topical HIV microbicides, application of imaging technologies in clinical pharmacology, empirical assessment of clinical research ethics.
|
|
|
|
 |
|
Teresa L. Parsons, PhD
Research Associate, Medicine |
|
Research
Interests:
Quantitative analysis of drugs and metabolites in clinical samples.
|
|
|
|
 |
|
Laura
Rocco, RN, MS
Research
Associate, Medicine |
|
Research
Interests:
Informed consent for clinical research;
institutional and investigator compliance
with research regulations
|
|
|
|
 |
|
Jane
Scocca, PhD
Research
Associate, Medicine |
|
Research
Interests:
Understanding the mechanisms
of drug cytotoxicity in trypanosomes and malaria
parasites and identification of potential
drug targets in these organisms; and many
aspects of glycobiology and particularly the
structure, synthesis and function of the carbohydrate
moieties of glycoproteins.
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
| |
 |
|
Ying J. Cao, MD, Ph.D.
Adjunct Assistant Professor - Medicine
Johns Hopkins University
|
|
Research
Interests:
Pharmacokinetic and pharmacodynamic modeling of drug action at cellular, tissue, and population level
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
